| 12312404 |
Anti-PVRIG antibodies and methods of use |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +8 more |
2025-05-27 |
|
| 11795220 |
Anti-PVRIG antibodies and methods of use |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +8 more |
2023-10-24 |
$599,000 |
| 11795209 |
PVRIG polypeptides and methods of treatment |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +13 more |
2023-10-24 |
$599,000 |
| 11701424 |
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +16 more |
2023-07-18 |
$2,196,000 |
| 11623955 |
Anti-PVRIG antibodies and methods of use |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +8 more |
2023-04-11 |
$1,091,000 |
| 11220542 |
Anti-PVRIG antibodies and methods of use |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +8 more |
2022-01-11 |
$5,163,000 |
| 10751415 |
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +16 more |
2020-08-25 |
$27,730,000 |
| 10550173 |
PVRIG polypeptides and methods of treatment |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +13 more |
2020-02-04 |
$7,930,000 |
| 10351625 |
Anti-PVRIG antibodies and methods of use |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +8 more |
2019-07-16 |
$2,917,000 |
| 10227408 |
Anti-PVRIG antibodies and methods of use |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +8 more |
2019-03-12 |
$3,054,000 |
| 10213505 |
Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +16 more |
2019-02-26 |
$2,955,000 |
| 10124061 |
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +16 more |
2018-11-13 |
$2,713,000 |
| 10098934 |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
Zurit Levine, Amir Toporik, Amit Novik, Anat Cohen-Dayag, Avi Rosenberg +12 more |
2018-10-16 |
$2,971,000 |
| 9714289 |
Anti-PVRIG antibodies and methods of use |
Mark White, Sandeep Kumar, Christopher Chan, Spencer Liang, Lance Stapleton +8 more |
2017-07-25 |
$2,172,000 |
| 9617336 |
C10RF32 antibodies, and uses thereof for treatment of cancer |
Gady S. Cojocaru, Galit Rotman, Zurit Levine, Ofer Levi, Raffaella Briante +3 more |
2017-04-11 |
$1,733,000 |
| 9555087 |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
Amir Toporik, Amit Novik, Anat Cohen-Dayag, Avi Rosenberg, Cynthia Koifman +12 more |
2017-01-31 |
$1,987,000 |
| 9375466 |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
Anat Cohen-Dayag, Merav Beiman, Marina Bubis, Shirley SAMEACH- GREENWALD, Dalit LANDESMAN-MILO +12 more |
2016-06-28 |
$3,201,000 |
| 9107862 |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
Amir Toporik, Amit Novik, Anat Cohen-Dayag, Avi Rosenberg, Cynthia Koifman +12 more |
2015-08-18 |
$2,418,000 |
| 8415455 |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
Zurit Levine, Tania Pergam, Dalit LANDESMAN-MILO, Anat Cohen-Dayag, Amir Toporik +12 more |
2013-04-09 |
$2,391,000 |